Pfizer loses bid to recoup $75 million left over from SEC settlement
A federal judge on Tuesday rejected Pfizer's bid to recoup about $75.2 million left over from a U.S. Securities and Exchange Commission settlement with billionaire Steven A. Cohen's hedge fund SAC ...
Opinion: Pfizer (PFE) Stock Will Hit $22 Before It Hits $33 During Trump's Presidency
Donald Trump's electoral victory has shaken the market, mostly in a good way.
This Beaten-Down Stock Just Gave Investors More Good News: Is it a Buy?
Slowly but surely, the company's prospects are looking more attractive.
3 Potential Catalysts That Could Lift Pfizer Stock Before 2025
The pipeline could yield a winner, but so could a few organizational changes.
Pfizer Is A Good Stock To Buy After The Earnings
PFE has beaten analyst estimate both top- and bottom line. The firm has also raised its full-year guidance. Investors have not taken the earnings news too positively, however, because significant p...
Baby Boomers: 2 Super-High-Yield Stocks to Watch in November
Baby Boomer investors who aren't happy with the falling rates on their savings and CDs may be enticed by the dividend stocks right about now.
Pfizer Covid sales boost prompts durability concerns - Bank of America
Pfizer Inc (NYSE:PFE, ETR:PFE)'s reliance on a rebound in demand for Covid-19 products in expectation-beating third-quarter results likely hit sentiment, according to Bank of America analysts. Thou...
3 Stocks to Buy Following Robust Quarterly Results
Throughout the Q3 reporting cycle, several companies, including Pfizer, Philip Morris, and Tenet Healthcare, have stolen the spotlight, with each raising guidance.
Pfizer, Inc. (PFE) Q3 2024 Earnings Call Transcript
Pfizer, Inc. (NYSE:PFE ) Q3 2024 Earnings Conference Call October 29, 2024 10:00 AM ET Company Participants Francesca DeMartino - Chief Investor Relations Officer & SVP Albert Bourla - Chairman & C...
Pfizer's Oncology Triumphs Keep Investors Hooked Amid Market Volatility
Despite today's fall in Pfizer's share price, it beat my and Wall Street analysts' expectations for the third quarter of 2024 by a large margin. Tafamidis franchise sales were $1.45 billion in Q3 2...
Pfizer Results May Temper Efforts for Shakeup Demanded by Activist Investor
Shares of Pfizer (PFE) fell Tuesday as a strong earnings report is seen as likely to limit activist investor Starboard Value from driving major changes at the drugmaker.
Pfizer ups guidance as demand for Covid-19 products grows
Pfizer Inc (NYSE:PFE, ETR:PFE) has lifted full-year revenue guidance on the back of a rebound in demand for its Covid-19 products. Revenue is expected to sit between $61 billion and $64 billion ove...
Pfizer Lifts Revenue Outlook, McDonald's Sees U.S. Sales Growth in Q3
Pfizer Q3 earnings beat expectations, driven by Paxlovid sales. Cost-saving goals aim for $4B by 2027 as Covid demand slows.
Pfizer, McDonald's Q3 Earnings to Set Early Market Tone; Alphabet, AMD Follow Post-Close
Pfizer's rebound and McDonald's E. coli impact headline pre-market earnings; post-close focus shifts to Alphabet and AMD.
Related Companies